Autres langues Sol-Gel Technologies Ltd.

Actions

SLGL

IL0011417206

Marché Fermé - Nasdaq Autres places de cotation 22:30:01 03/05/2024			Varia. 5j.	Varia. 1 janv.
0,8504 ^USD	+0,05 %		-4,41 %	-23,04 %

13/03	Sol-Gel Technologies Ltd. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI
29/02	Sol-Gel Technologies Ltd. élit Yuval Yanai en tant qu'administrateur externe	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Sol-Gel’s Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream	01/04
Sol-Gel Technologies Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	13/03
Sol-Gel Reports Full-Year 2023 Financial Results and Corporate Developments	13/03
Sol-Gel Technologies Ltd. Elects Yuval Yanai as External Director	29/02
Sol-Gel Technologies Ltd. Screens First Patient for SGT-610 Phase 3 Study	30/11
Sol-Gel Technologies Screens First Patient for SGT-610 Phase 3 Study	30/11
Sol-Gel Technologies Ltd to Host Virtual KOL Event on Gorlin Syndrome and the Upcoming Phase 3 Trial for SGT-610	28/11
Sol Gel Technologies : INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K - Form 6-K	20/11
Sol-Gel Technologies Ltd. Announces Resignation of Shmuel Ben Zvi from Board	20/11
Sol-Gel Technologies Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11
Sol-Gel Technologies Reports Third Quarter 2023 Financial Results and Provides Corporate Update	09/11
Sol-Gel Technologies to Participate in the H.C. Wainwright 25th Annual Global Investment Conference	30/08/23
Sol-Gel Technologies Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10/08/23
Sol-Gel Technologies Reports Second Quarter 2023 Financial Results and Provides Corporate Update	10/08/23
Sol-Gel Technologies Ltd. Appoints Sharon Kochan to the Board of Directors	27/07/23
Sol Gel Technologies : NOTICE OF ANNUAL MEETING OF SHAREHOLDERS - Form 6-K	21/06/23
Sol Gel Technologies : NOTICE OF ANNUAL MEETING OF SHAREHOLDERS - Form 6-K	14/06/23
Sol-Gel Technologies, Searchlight Pharma Sign Licensing Deals for 2 Dermatology Drugs	06/06/23
Sol-Gel and Searchlight Pharma Announce Licensing Agreements to Commercialize TWYNEO® and EPSOLAY® in Canada	06/06/23
Sol-Gel and Searchlight Pharma Announce Licensing Agreements to Commercialize TWYNEO and EPSOLAY in Canada	06/06/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Sol-Gel Technologies Ltd.

Actions

SLGL

IL0011417206

Autres langues

Filtres